Involvement of tyrosine kinase activity in 1α,25(OH)2-vitamin D3 signal transduction in skeletal muscle cells

被引:34
|
作者
Morelli, S [1 ]
Buitrago, C [1 ]
Vazquez, G [1 ]
De Boland, AR [1 ]
Boland, R [1 ]
机构
[1] Univ Nacl Sur, Dept Biol Bioquim & Farm, RA-8000 Bahia Blanca, Buenos Aires, Argentina
关键词
D O I
10.1074/jbc.M002025200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In cultured chick skeletal muscle cells loaded with Fura-a, the tyrosine kinase inhibitors herbimycin A and genistein abolished both the fast inositol 1,4,5-trisphosphatedependent Ca2+ release from internal stores and extracellular Ca2+ influx induced by 1 alpha ,25(OH)(2)-vitamin D-3 (1 alpha ,25(OH)(2)D-3). Daidzein, an inactive analog of genistein, was without effects. Tyrosine phosphatase inhibition by orthovanadate increased cytosolic Ca2+. Antiphosphotyrosine immunoblot analysis revealed that 1 alpha ,2S(OH)(2)D-3 rapidly (0.5-10 min) stimulates in a concentrationdependent fashion (0.1-10 nM) tyrosine phosphorylation of several myoblast proteins, among which the major targets of the hormone could be immunochemically identified as phospholipase C gamma (127 kDa), which mediates intracellular store Ca2+ mobilization and external Ca2+ influx, and the growth-related proteins mitogen-activated protein (MAP) kinase (42/44 kDa) and c-myc (65 kDa), Genistein suppressed the increase in phosphorylation and concomitant elevation of MAPK activity elicited by the sterol, Both genistein and the MAPK kinase (MEK) inhibitor PD98059 abolished stimulation of DNA synthesis by 1 alpha ,25(OH)(2)D-3. The sterol-induced increase in tyrosine phosphorylation of c-myc, a finding not reported before for cell growth regulators, was totally suppressed by the specific Src inhibitor PP1, These results demonstrate that tyrosine phosphorylation is a previously unrecognized mechanism involved in 1 alpha ,25(OH)(2)D-3 regulation of Ca2+ homeostasis in hormone target cells. In addition, the data involve tyrosine kinase cascades in the mitogenic effects of 1 alpha ,25(OH)(2)D-3 on skeletal muscle cells.
引用
收藏
页码:36021 / 36028
页数:8
相关论文
共 50 条
  • [2] The stimulation of MAP kinase by 1,25(OH)2-vitamin D3 in skeletal muscle cells is mediated by protein kinase C and calcium
    Morelli, S
    Buitrago, C
    Boland, R
    de Boland, AR
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 173 (1-2) : 41 - 52
  • [3] VDR and P38 mapk involvement in 1α,25(OH)2-vitamin D3 modulation of myogenesis in skeletal muscle cells
    Irazoqui, A. P.
    Heim, N.
    Boland, R. L.
    Buitrago, C. G.
    BONE, 2016, 83 : 277 - 277
  • [4] 1α,25(OH)2-vitamin D3 actions in skeletal muscle cells:: Intracellular signaling through MAPKs
    Buitrago, CG
    de Boland, AR
    Boland, R
    BONE, 2005, 37 (01) : 129 - 129
  • [5] The tyrosine kinase c-Src is required for 1,25(OH)2-vitamin D3 signalling to the nucleus in muscle cells
    Buitrago, C
    Boland, RL
    de Boland, AR
    BONE, 2001, 28 (05) : S247 - S247
  • [6] The tyrosine kinase c-Src is required for 1,25(OH)2-vitamin D3 signalling to the nucleus in muscle cells
    Buitrago, C
    Boland, R
    de Boland, AR
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2001, 1541 (03): : 179 - 187
  • [7] 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells
    Capiati, D
    Benassati, S
    Boland, RL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, 86 (01) : 128 - 135
  • [8] Modulation of tyrosine phosphorylation signalling pathways by 1α,25(OH)2-vitamin D3
    Boland, R
    Buitrago, C
    De Boland, AR
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (06): : 280 - 287
  • [9] 1,25(OH)2-vitamin D3 affects the subcellular distribution of protein kinase C isoenzymes in muscle cells
    Marinissen, MJ
    Capiati, D
    Boland, R
    CELLULAR SIGNALLING, 1998, 10 (02) : 91 - 100
  • [10] Molecular tools for study of genomic and rapid signal transduction responses initiated by 1α,25(OH)2-vitamin D3
    Norman, AW
    Bishop, JE
    Bula, CM
    Olivera, CJ
    Mizwicki, MT
    Zanello, LP
    Ishida, H
    Okamura, WH
    STEROIDS, 2002, 67 (06) : 457 - 466